Related Experiment Video
Updated: Jul 6, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Incorporating correlation in interindividual variability for the optimal design of multiresponse pharmacokinetic
Kayode Ogungbenro1, Gordon Graham, Ivelina Gueorguieva
1Centre for Applied Pharmacokinetics Research, University of Manchester, Manchester, United Kingdom. kayode.ogungbenro@manchester.ac.uk
Abstract:
This paper presents a method for optimal design of multiresponse population pharmacokinetic experiments taking into account correlations between interindividual variances. Expressions for the population Fisher information matrix have been defined for uniresponse and multiresponse pharmacokinetic experiments. A major assumption often made is that the variance-covariance matrix of the interindividual variance components has only diagonal elements so that whenever intersubject covariance elements are present, they are ignored during the design of the experiment. Recently expressions that accounted for these off diagonal elements were developed for uniresponse population pharmacokinetic experiments. The work presented here extends these expressions to multiresponse population pharmacokinetic experiments. These were applied to a population pharmacokinetic model, a population pharmacokinetic-pharmacodynamic model, and a parent-metabolite pharmacokinetic model example. The results obtained showed that optimal designs are different with diagonal omega matrix and full omega matrix and ignoring the off diagonal elements can lead to a design that produces more biased and less precise parameter estimates compared to a design that includes the off diagonal elements. The results also showed correlation between residual components of the responses has an effect on the optimal design.
More Related Videos
07:37An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects
Published on: January 9, 2020
20:24Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
Published on: January 31, 2014
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Drug Product Performance: In Vitro–In Vivo Correlation
Dosage Regimen: Individualization
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.